To explore ways to overcome cancer cells' resistance to cisplatin, investigators from Cedars-Sinai, the University of Colorado Anschutz Medical Campus, and Erasmus University Medical Center ...

Grade 2 SCr elevations were rarely observed in both groups (1.6% in SH, 2.8% in CH). Rate of cisplatin modification was similar between the two groups. Out of 82 patients with HNC, the rate of SCr ...

to standard-of-care radiation therapy and cisplatin. Overall survival in locally advanced/metastatic EGFR-mutated non-small cell lung cancer improved significantly with first-line amivantamab ...